Suppr超能文献

临床和环境烟曲霉分离株中唑类耐药的基因组视角,这些分离株中没有 cyp51A 突变。

Genomic perspective of triazole resistance in clinical and environmental Aspergillus fumigatus isolates without cyp51A mutations.

机构信息

Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India.

Interdiciplinary Biology, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, India.

出版信息

Fungal Genet Biol. 2019 Nov;132:103265. doi: 10.1016/j.fgb.2019.103265. Epub 2019 Aug 26.

Abstract

Aspergillus fumigatus is the most common etiologic agent of primarily all clinical manifestations of aspergillosis. A steady increase in the number of azole resistant A. fumigatus (ARAF) isolates from environment and clinical samples leading to therapeutic failures in clinical settings have alarmed the mycologists and clinicians worldwide. Although mutations in azole target cyp51A gene have been implicated in conferring azole resistance in A. fumigatus, recent studies have demonstrated occurrence of azole resistant strains without cyp51A mutations. In this study, next generation sequencing techniques and the expression profiling of transporter genes with single nucleotide polymorphisms (SNPs) in clinical and environmental ARAF isolates with (G54E) and without known cyp51A mutations was undertaken to understand the genetic background and role of transporters in azole resistance. The raw reads of four ARAF strains when mapped to Af293 reference genome (>100X depth) covered at least 93.1% of the reference genome. Among all four strains, a total of 212,711 SNPs was identified with 37,829 were common in at least two isolates. The expression analysis suggested the overexpression of MFS transporter, namely, mfsC in all ARAF isolates. None of the resistant strain showed significant upregulation of cyp51A and cyp51B gene. On the other hand, abcD was upregulated (5-fold) in the isolates with cyp 51A mutation (G54E). The whole genome sequence analysis showed the presence of two previously described amino acid substitutions S269F and F390Y in HMG1 gene in a clinical panazole resistant strain without cyp51A mutations. These mutations have been previously associated with azole resistance in A. fumigatus strains without cyp51A mutations. Further, several punctual mutations and a large-segment deletion among different strains were observed suggesting the involvement of resistance mechanisms other than cyp51A.

摘要

烟曲霉是最常见的主要所有临床曲霉菌病的病因。环境和临床样本中唑类耐药烟曲霉(ARAF)分离株的数量不断增加,导致临床治疗失败,这引起了世界各地的真菌学家和临床医生的警惕。虽然唑类药物靶标 cyp51A 基因的突变已被认为是赋予烟曲霉唑类耐药性的原因,但最近的研究表明,即使没有 cyp51A 突变也会出现唑类耐药株。在这项研究中,采用下一代测序技术和单核苷酸多态性(SNP)的转运蛋白基因表达谱分析,对具有(G54E)和无已知 cyp51A 突变的临床和环境 ARAF 分离株进行研究,以了解遗传背景和转运蛋白在唑类耐药中的作用。当将四个 ARAF 菌株的原始读数映射到 Af293 参考基因组(>100X 深度)时,至少覆盖了参考基因组的 93.1%。在所有四个菌株中,共鉴定出 212711 个 SNP,其中 37829 个 SNP 在至少两个分离株中是共同的。表达分析表明,所有 ARAF 分离株中的多药外排转运蛋白 MFS 基因 mfsC 过表达。没有一个耐药株显示 cyp51A 和 cyp51B 基因的显著上调。另一方面,在具有 cyp51A 突变(G54E)的分离株中,abcD 上调(5 倍)。全基因组序列分析显示,在一个没有 cyp51A 突变的临床泛唑类耐药株中,HMG1 基因存在先前描述的两个氨基酸取代 S269F 和 F390Y。这些突变先前与没有 cyp51A 突变的烟曲霉菌株的唑类耐药性有关。此外,在不同菌株中观察到几个点状突变和一个大的片段缺失,这表明存在其他耐药机制,而不仅仅是 cyp51A。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验